4Diverio D,Rossi V,Avvisati G,et al.Early dete ction of relapse by prospective reverse transcriptase-polymerase chain reactin analysis of the PMIL/RAR alpha fusion gene in patients with acute promyelocytic leukemia enrolled in the GIMEMA-AIEOP multicenter"AIDA"trial GIMEMA-AIEOP Muhicenter "AIDA"trial[J].Blood,1998,92:784-789.
5Latagliata R,Petti MC,Fenu S,et al.Therapy-r elated myelodysplastic syndrome-acute myelogenous leukemia in patients treated for acut e promyelocytic leukemia:an emerging problem[J].Blood,2002;99:822-824.
7Kantarjian H, Ravandi F, O'Brien, et al. Intensive chemotherapy does not benefit most older patients (age 70 years or older) with acute myeloid leukemia [J]. Blood, 2010, 116: 4422-4429.
8Isidori A, Venditti A, Maurillo L, et al. Alternative novel therapies for the treatment of elderly acute myeloid leukemia patients[J]. Expert Rev Hematol, 2013, 6:767-784.
9Baz R, Rodriguez C, Fu AZ, et al. Impact of remission induction chemotherapy on survival in older adults with acute myeloid leukemia[J]. Cancer, 2007, 110:1752-1759.
10Juliusson G, Antunovic P, Derolf A, et al. Age and acute myeloid leukemia: real world data on decision to treat and outcomes from the Swedish Acute Leukemia Registry [J] . Blood, 2009, 113: 4179-4187.
